Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-004296
Filing Date
2020-07-29
Accepted
2020-07-29 09:02:51
Documents
4
Period of Report
2020-09-09
Effectiveness Date
2020-07-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2242151zdef14a.htm DEF 14A 373210
2 G802909.JPG g802909.jpg GRAPHIC 19254
3 G232272BII001.GIF g232272bii001.gif GRAPHIC 116488
4 G232272BII002.GIF g232272bii002.gif GRAPHIC 132216
  Complete submission text file 0001047469-20-004296.txt   743540
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38596 | Film No.: 201055917
SIC: 2836 Biological Products, (No Diagnostic Substances)